Friday, August 3, 2018

Millennium TVP Management Co., LLC Buys Spotify Technology SA, Sells Facebook Inc

New York, NY, based Investment company Millennium TVP Management Co., LLC buys Spotify Technology SA, sells Facebook Inc during the 3-months ended 2018-06-30, according to the most recent filings of the investment company, Millennium TVP Management Co., LLC. As of 2018-06-30, Millennium TVP Management Co., LLC owns 6 stocks with a total value of $110 million. These are the details of the buys and sells.

New Purchases: SPOT, Reduced Positions: CHGG, RNET, Sold Out: FB,

For the details of Millennium TVP Management Co., LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Millennium+TVP+Management+Co.%2C+LLC

These are the top 5 holdings of Millennium TVP Management Co., LLCChegg Inc (CHGG) - 1,353,007 shares, 34.27% of the total portfolio. Shares reduced by 13.54%Sunrun Inc (RUN) - 2,037,971 shares, 24.43% of the total portfolio. Alibaba Group Holding Ltd (BABA) - 138,155 shares, 23.36% of the total portfolio. Spotify Technology SA (SPOT) - 104,433 shares, 16.01% of the total portfolio. New PositionTelaria Inc (TLRA) - 368,034 shares, 1.36% of the total portfolio. New Purchase: Spotify Technology SA (SPOT)

Millennium TVP Management Co., LLC initiated holding in Spotify Technology SA. The purchase prices were between $143.99 and $180.94, with an estimated average price of $159.94. The stock is now traded at around $179.71. The impact to a portfolio due to this purchase was 16.01%. The holding were 104,433 shares as of 2018-06-30.

Sold Out: Facebook Inc (FB)

Millennium TVP Management Co., LLC sold out a holding in Facebook Inc. The sale prices were between $155.1 and $202, with an estimated average price of $180.53.



Here is the complete portfolio of Millennium TVP Management Co., LLC. Also check out:

1. Millennium TVP Management Co., LLC's Undervalued Stocks
2. Millennium TVP Management Co., LLC's Top Growth Companies, and
3. Millennium TVP Management Co., LLC's High Yield stocks
4. Stocks that Millennium TVP Management Co., LLC keeps buying

Thursday, August 2, 2018

A long-time bull debunks 'peak earnings' fears, sees strong year-end rally

Long-time bull Art Hogan sees holes in the "peak earnings" argument.

According to the B. Riley FBR chief market strategist, earnings growth on a year-over-year basis will crest this year �� but that doesn't mean it's as good as it gets for investors. He believes the economic picture supports the case for a fresh round of strong numbers that will drive stocks to record highs.

"Earnings growth is going to continue. It's just difficult comps versus 2018," Hogan said Wednesday on CNBC's "Trading Nation."

As of Wednesday's market close, Thomson Reuters reports 81 percent of second-quarter earnings reports have come in above estimates. Since 1994, an average of 64 percent of companies beat estimates.

The long-time bull acknowledges the latest earnings have vastly benefited from the 2017 one-time corporate tax cut. But that's no reason to second-guess the bull market, he said.

"Obviously, we've had great earnings in 2018 thus far," Hogan said.

His year-end S&P 500 target is 3,000, up more than 6 percent from current levels or 4 percent from its all-time high hit on Jan. 26.

Hogan is citing more than just strong earnings as his a chief catalyst. He believes the Trump administration will use midterm elections as a reason to end the trade war, in turn easing uncertainty on Wall Street.

"Right now, we're just pricing in bad news, and that continues to escalate with China. We're starting to see some cracks and some olive branches being brought forward," Hogan said. "That will start to ease some of the concerns corporate America has about trade and tariffs."

Vote Vote to see results Total Votes:

Not a Scientific Survey. Results may not total 100% due to rounding.

show chapters Peak earnings season fears are overblown, says market strategist Art Hogan 'Peak earnings' fears are overblown, says market strategist Art Hogan    16 Hours Ago | 04:24 Disclaimer

Wednesday, August 1, 2018

At Long Last, Facebook Turns on WhatsApp Monetization

It's now been over a year since Facebook (NASDAQ:FB) subsidiary WhatsApp started hiring for a "product manager for monetization," which came a few months before the popular messaging service officially launched WhatsApp Business. The social networking titan has been working on a new monetization model for WhatsApp for several years, after eliminating�the paltry $1-per-year subscription fee in 2016 shortly after acquiring the start-up.

Instead, Facebook wants to monetize WhatsApp (and Messenger) by helping businesses connect directly with consumers, and it just made a big move in that direction.

WhatsApp logo

Image source: WhatsApp.

Charging businesses to connect with you

Facebook�and WhatsApp�today announced the launch of the WhatsApp Business API, which companies can use to manage their conversations with customers at scale. The WhatsApp Business app on Android now has over 3 million users, according to a Facebook blog post.

Using the new suite of tools, businesses can exchange or provide information to customers, make it easier for customers to initiate conversations by integrating a click-to-chat button, and offer real-time support. Users will be able to easily block any business that might be sending too many unsolicited messages.

Business customers will foot the bill, paying anywhere from�0.5 cents to 9 cents per message sent, depending on the geographical market. The great irony there is that WhatsApp's popularity was largely propelled by being incredibly affordable, making the service a very compelling alternative to traditional SMS text messaging in emerging markets, yet now the company's messaging rates will be significantly more expensive than SMS rates, which are usually less than 1 cent per SMS message. Of course, the big difference is that only business customers will have to pay, while the service remains free for users.

WhatsApp argues that charging businesses per message may help ensure that the messages "are selective and your chats don't get cluttered."

Pressure to monetize

The news comes at a tumultuous point in time for WhatsApp, which has seen co-founders Brian Acton and Jan Koum leave Facebook within the past year amid disagreements over data practices.

Facebook CEO Mark Zuckerberg and COO Sheryl Sandberg also reportedly pressured Acton and Koum to "move faster" because Zuck and Sandberg "grew impatient for a greater return" on the blockbuster $22 billion acquisition. It's possible that Facebook is worried about recognizing a goodwill impairment charge, should WhatsApp fail to live up to the lofty financial expectations that inevitably get priced in when you pay roughly 1,000 times sales for a start-up.

As revenue growth slows and costs rise on Facebook's core platform, pinching profitability in the process, the company is increasingly turning to its other properties in an effort to satisfy investors' growth appetites.

Saturday, July 21, 2018

Wells Fargo & Co (WFC) Shares Sold by Osborn Williams & Donohoe LLC

Osborn Williams & Donohoe LLC trimmed its stake in shares of Wells Fargo & Co (NYSE:WFC) by 36.8% in the 2nd quarter, HoldingsChannel reports. The fund owned 63,193 shares of the financial services provider’s stock after selling 36,770 shares during the period. Osborn Williams & Donohoe LLC’s holdings in Wells Fargo & Co were worth $3,503,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Massachusetts Financial Services Co. MA lifted its position in Wells Fargo & Co by 5.2% during the first quarter. Massachusetts Financial Services Co. MA now owns 50,957,630 shares of the financial services provider’s stock valued at $2,670,689,000 after purchasing an additional 2,497,659 shares during the last quarter. Geode Capital Management LLC lifted its position in Wells Fargo & Co by 1.3% during the fourth quarter. Geode Capital Management LLC now owns 46,311,774 shares of the financial services provider’s stock valued at $2,803,705,000 after purchasing an additional 584,764 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in Wells Fargo & Co by 1.8% during the first quarter. Dimensional Fund Advisors LP now owns 41,213,847 shares of the financial services provider’s stock valued at $2,160,018,000 after purchasing an additional 722,334 shares during the last quarter. Magellan Asset Management Ltd lifted its position in Wells Fargo & Co by 24.1% during the first quarter. Magellan Asset Management Ltd now owns 31,024,898 shares of the financial services provider’s stock valued at $1,626,015,000 after purchasing an additional 6,017,222 shares during the last quarter. Finally, Boston Partners lifted its position in Wells Fargo & Co by 10.1% during the first quarter. Boston Partners now owns 18,850,437 shares of the financial services provider’s stock valued at $987,951,000 after purchasing an additional 1,732,956 shares during the last quarter. 76.05% of the stock is owned by institutional investors.

Get Wells Fargo & Co alerts:

In related news, EVP Petros G. Pelos sold 25,567 shares of Wells Fargo & Co stock in a transaction dated Thursday, May 24th. The shares were sold at an average price of $54.76, for a total transaction of $1,400,048.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.09% of the company’s stock.

Several research firms have commented on WFC. Zacks Investment Research upgraded shares of Wells Fargo & Co from a “hold” rating to a “buy” rating and set a $63.00 price objective for the company in a research report on Thursday. Morgan Stanley lowered their target price on shares of Wells Fargo & Co from $62.00 to $61.00 and set an “equal weight” rating for the company in a report on Monday, July 16th. Keefe, Bruyette & Woods upgraded shares of Wells Fargo & Co from a “market perform” rating to an “outperform” rating and raised their target price for the stock from $57.00 to $63.00 in a report on Sunday, July 15th. They noted that the move was a valuation call. Susquehanna Bancshares set a $63.00 target price on shares of Wells Fargo & Co and gave the stock a “hold” rating in a report on Friday, July 13th. Finally, Macquarie upgraded shares of Wells Fargo & Co from an “underperform” rating to an “outperform” rating in a report on Monday, April 30th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and sixteen have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $62.50.

Wells Fargo & Co opened at $56.41 on Friday, MarketBeat Ratings reports. Wells Fargo & Co has a 12-month low of $49.27 and a 12-month high of $66.31. The stock has a market capitalization of $274.76 billion, a PE ratio of 13.38, a PEG ratio of 1.52 and a beta of 1.14. The company has a debt-to-equity ratio of 1.22, a current ratio of 0.88 and a quick ratio of 0.86.

Wells Fargo & Co Company Profile

Wells Fargo & Company, a diversified financial services company, provides retail, commercial, and corporate banking services to individuals, businesses, and institutions. The company's Community Banking segment offers checking and savings accounts; credit and debit cards; and automobile, student, mortgage, home equity, and small business loans.

Recommended Story: What does relative strength index mean?

Want to see what other hedge funds are holding WFC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Wells Fargo & Co (NYSE:WFC).

Institutional Ownership by Quarter for Wells Fargo & Co (NYSE:WFC)

Friday, July 20, 2018

Dollar sees biggest one-day drop in 3 weeks after Trump comments

The U.S. dollar got pummeled on Friday after President Donald Trump accused China and the European Union of currency and interest-rate manipulation that he says has put the U.S. at a disadvantage.

The ICE U.S. Dollar Index DXY, -0.73% traded 0.7% lower to 94.478 after the tweets, marking its worst performance in three weeks.

China, the European Union and others have been manipulating their currencies and interest rates lower, while the U.S. is raising rates while the dollars gets stronger and stronger with each passing day - taking away our big competitive edge. As usual, not a level playing field...

— Donald J. Trump (@realDonaldTrump) July 20, 2018

....The United States should not be penalized because we are doing so well. Tightening now hurts all that we have done. The U.S. should be allowed to recapture what was lost due to illegal currency manipulation and BAD Trade Deals. Debt coming due & we are raising rates - Really?

— Donald J. Trump (@realDonaldTrump) July 20, 2018

That was enough to turn the gauge, which measures the greenback against six major rivals, negative for both the week and the month, according to FactSet. On the week, the index is down 0.3%, while it is down 0.2% in July. The broader WSJ Dollar Index BUXX, -0.71% was down 0.7% at 88.24, as most emerging market currencies rallied as the buck weakened.

It was the second time in less than 24 hours that the president��s comments rattled the buck, after Trump suggested he could slap more tariffs on China and said he wasn��t ��thrilled�� with the Fed raising rates in an interview with CNBC on Thursday.

Don��t miss: Why it matters that the spread between China��s onshore and offshore yuan is widening

In the interview, which aired in full earlier Friday morning, the president said he was prepared to put tariffs on all $505 billion in Chinese goods imported to the U.S., once again stepping up his rhetoric in the continuing trade spat.

Check out: Japan��s yen has become the clearest ��expression of the effect of a trade war��

A first excerpt of the interview was published late Thursday, including Trump��s criticism of the Federal Reserve��s monetary tightening. This led the U.S. dollar to drop into negative territory following a buoyant day, as investors read the comments as an attack on the central bank��s independence. Trump was also concerned the Fed would follow through on the projected two additional interest rate hikes this year, according to a CNBC report.

Read: Trump rips Fed rate hikes, but investors expect Powell to stay the course

In the interview, Trump also touched on currencies, saying China��s yuan was ��dropping like a rock.�� The onshore yuan USDCNY, -0.0251% has fallen 4.2% in 2018. Both the currency and the People��s Bank of China that sets its reference rate have been closely watched by investors, some of which worry that the central bank could devalue its currency as a tactic in trade negotiations. The buck last fetched 6.7689 yuan, down 0.1% from Thursday.

The PBOC weakened the yuan by the most in two years on Friday, setting the dollar-yuan reference rate to 6.7671. The central bank sets the onshore yuan daily a range of 2% in either direction.

��Given the pace of the yuan��s weakness, many participants argued that officials have weaponized it,�� wrote Brown Brothers Harriman currency strategists Marc Chandler and Win Thin in a note. ��We find the claims unpersuasive.��

The more freely traded offshore yuan USDCNH, -0.1958% is down 4.1% in the year, and one dollar last bought 6.7753 yuan, little changed.

The Chinese currency��s weakness was following a year of strength, they argued. ��Second, the PBOC is easing policy while it [is] still trying to force some deleveraging.�� Also, the limited value-added yuan costs incurred in production processes would mean that export prices wouldn��t be ��particularly sensitive to movement��s in the yuan��s exchange rate,�� the strategists said.

Finally, ��the foreign exchange market is better characterized by a strong dollar than a weak yuan,�� the BBH analysts said, adding, ��while typically central banks prefer their currency move in the same direction as monetary policy, currency depreciation is a blunt tool and could complicate other Chinese policy goals, including financial stability.��

Trade remains the dominant topic of the day, with the Group of 20 finance ministers meeting in Buenos Aires for a summit that will be focused on trade and the global economy.

Anneken Tappe

Anneken Tappe is a markets reporter for MarketWatch. She is based in New York.

We Want to Hear from You

Join the conversation

Comment var SA = SA || []; SA.push({ container: "#sa_calc_246908", version: 1.1, data: { key: "npqzoaaw8ttdneqrelpmx2gdnehdyiog" } }); var smscript = document.createElement('script'); smscript.type = 'text/javascript'; smscript.async = true;

Thursday, July 19, 2018

Top 10 Medical Stocks For 2019

tags:PX,MCBC,LXRP,EWJ,INN,TOP,THG,CLF,EQIX,BNS,

Stephens Inc. AR boosted its holdings in shares of Medtronic (NYSE:MDT) by 8.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 119,490 shares of the medical technology company’s stock after purchasing an additional 9,044 shares during the quarter. Stephens Inc. AR’s holdings in Medtronic were worth $9,586,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the business. BlackRock Inc. lifted its position in shares of Medtronic by 6.4% in the fourth quarter. BlackRock Inc. now owns 94,595,580 shares of the medical technology company’s stock valued at $7,638,592,000 after acquiring an additional 5,688,180 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Medtronic by 2.5% in the fourth quarter. Geode Capital Management LLC now owns 14,191,675 shares of the medical technology company’s stock valued at $1,143,549,000 after acquiring an additional 351,256 shares in the last quarter. Wells Fargo & Company MN lifted its position in shares of Medtronic by 5.9% in the first quarter. Wells Fargo & Company MN now owns 13,941,900 shares of the medical technology company’s stock valued at $1,118,419,000 after acquiring an additional 782,123 shares in the last quarter. Sanders Capital LLC lifted its position in shares of Medtronic by 2.0% in the fourth quarter. Sanders Capital LLC now owns 7,526,583 shares of the medical technology company’s stock valued at $667,410,000 after acquiring an additional 144,100 shares in the last quarter. Finally, Janus Henderson Group PLC purchased a new position in shares of Medtronic in the third quarter valued at approximately $579,952,000. Institutional investors own 81.86% of the company’s stock.

Top 10 Medical Stocks For 2019: Pound/Rand(PX)

Advisors' Opinion:
  • [By Logan Wallace]

    D.A. Davidson & CO. boosted its position in shares of Praxair (NYSE:PX) by 78.0% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 5,321 shares of the basic materials company’s stock after acquiring an additional 2,332 shares during the quarter. D.A. Davidson & CO.’s holdings in Praxair were worth $768,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Neuberger Berman Group LLC lowered its position in Praxair (NYSE:PX) by 27.3% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 247,173 shares of the basic materials company’s stock after selling 92,983 shares during the period. Neuberger Berman Group LLC’s holdings in Praxair were worth $35,712,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    PX (CURRENCY:PX) traded down 5.3% against the dollar during the 1-day period ending at 22:00 PM E.T. on June 11th. One PX coin can now be bought for approximately $0.0010 or 0.00000014 BTC on exchanges. Over the last seven days, PX has traded down 30.7% against the dollar. PX has a total market capitalization of $94,640.00 and approximately $2.00 worth of PX was traded on exchanges in the last 24 hours.

  • [By Lisa Levin] Companies Reporting Before The Bell General Motors Company (NYSE: GM) is projected to report quarterly earnings at $1.24 per share on revenue of $34.66 billion. Bristol-Myers Squibb Company (NYSE: BMY) is estimated to report quarterly earnings at $0.85 per share on revenue of $5.24 billion. United Parcel Service, Inc. (NYSE: UPS) is expected to report quarterly earnings at $1.55 per share on revenue of $16.44 billion. Time Warner Inc. (NYSE: TWX) is projected to report quarterly earnings at $1.74 per share on revenue of $7.91 billion. ConocoPhillips (NYSE: COP) is expected to report quarterly earnings at $0.74 per share on revenue of $8.81 billion. PepsiCo, Inc. (NYSE: PEP) is expected to report quarterly earnings at $0.93 per share on revenue of $12.4 billion. American Airlines Group Inc. (NASDAQ: AAL) is estimated to report quarterly earnings at $0.72 per share on revenue of $10.42 billion. Southwest Airlines Co (NYSE: LUV) is expected to report quarterly earnings at $0.74 per share on revenue of $5.01 billion. Fiat Chrysler Automobiles N.V. (NYSE: FCAU) is estimated to report quarterly earnings at $0.8 per share on revenue of $34.52 billion. Union Pacific Corporation (NYSE: UNP) is projected to report quarterly earnings at $1.66 per share on revenue of $5.38 billion. D.R. Horton, Inc. (NYSE: DHI) is expected to report quarterly earnings at $0.85 per share on revenue of $3.76 billion. The Hershey Company (NYSE: HSY) is estimated to report quarterly earnings at $1.4 per share on revenue of $1.94 billion. Praxair, Inc. (NYSE: PX) is expected to report quarterly earnings at $1.56 per share on revenue of $2.94 billion. Altria Group, Inc. (NYSE: MO) is projected to report quarterly earnings at $0.92 per share on revenue of $4.63 billion. Shire plc (NASDAQ: SHPG) is estimated to report quarterly earnings at $3.54 per share on revenue of $3.72 billion. Oshkosh Corporation (NYSE: OSK) is projected to report quarter
  • [By Shane Hupp]

    Natixis Advisors L.P. lowered its stake in Praxair, Inc. (NYSE:PX) by 23.2% in the 1st quarter, HoldingsChannel reports. The fund owned 28,377 shares of the basic materials company’s stock after selling 8,583 shares during the quarter. Natixis Advisors L.P.’s holdings in Praxair were worth $4,095,000 at the end of the most recent quarter.

Top 10 Medical Stocks For 2019: Macatawa Bank Corporation(MCBC)

Advisors' Opinion:
  • [By Ethan Ryder]

    BidaskClub upgraded shares of Macatawa Bank (NASDAQ:MCBC) from a buy rating to a strong-buy rating in a research note released on Friday morning.

    Separately, Hovde Group set a $11.00 price target on Macatawa Bank and gave the stock a hold rating in a research report on Monday, January 29th.

  • [By Max Byerly]

    Chemical Financial (NASDAQ: CHFC) and Macatawa Bank (NASDAQ:MCBC) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability and risk.

Top 10 Medical Stocks For 2019: Lexaria Bioscience (LXRP)

Advisors' Opinion:
  • [By ]

    Here is the list of the cannabis companies that we track.

    Name Currency Ticker Canopy Growth Corp. CAD (CGC) Aurora Cannabis Inc. CAD (ACBFF) Aphria Inc. CAD (APHQF) MedReleaf Corp. CAD (OTCPK:MEDFF) Cronos Group CAD (CRON) The Green Organic Dutchman CAD (OTC:TGODF) CannTrust CAD (OTC:CNTTF) Hydropothecary Corp/The CAD (HYYDF) Cannabis Wheaton Income CAD (OTCQB:CBWTF) Emerald Health Therapeutics Inc. CAD (OTCQX:EMHTF) Organigram Holdings Inc. CAD (OTCQB:OGRMF) TerrAscend Corp. CAD (OTC:TRSSF) Supreme Cannabis Co Inc./The CAD (OTCPK:SPRWF) Hiku Brands CAD (OTCPK:DJACF) ABcann Global Corp. CAD (OTCQB:ABCCF) Radient Technologies Inc. CAD (OTC:RDDTF) Village Farms International Inc. CAD (OTCQX:VFFIF) Namaste Technologies CAD (OTCQB:NXTTF) MPX Bioceutical Corp. CAD (OTCQB:MPXEF) Sunniva CAD (OTCQX:SNNVF) MYM Nutraceuticals Inc. CAD (OTCQB:MYMMF) Maricann Group Inc. CAD (OTCQB:MRRCF) Cannabix Technologies Inc. CAD (OTCPK:BLOZF) THC Biomed INTL. Ltd. CAD (OTCQB:THCBF) ICC Labs Inc. CAD (OTC:ICCLF) WeedMD Inc. CAD (OTCPK:WDDMF) CannaRoyalty Corp. CAD (OTCQX:CNNRF) InMed Pharmaceuticals Inc. CAD (OTCQX:IMLFF) Harvest One Cannabis Inc. CAD (OTC:HRVOF) Golden Leaf Holdings Inc. CAD (OTCQB:GLDFF) Benchmark Botanics Inc. CAD (OTCPK:BHHKF) Friday Night Inc. CAD (OTCQB:TGIFF) Valens Groworks Corp. CAD (OTC:MYMSF) Invictus MD CAD (IVITF) Emblem Corp. CAD (OTCPK:EMMBF) Tetra Bio-Pharma Inc. CAD (OTCQB:TBPMF) Maple Leaf Green World Inc. CAD (OTCQB:MGWFF) Delta 9 Cannabis Inc. CAD (OTC:VRNDF) Nutritional High International Inc. CAD (OTCQB:SPLIF) Lifestyle Delivery Systems Inc. CAD (OTCQX:LDSYF) Marapharm Ventures Inc. CAD (OTCQX:MRPHF) Wildflower Marijuana Inc. CAD (OTC:WLDFF) Indiva Ltd. CAD (OTC:RMKXD) Hempco Food And Fiber Inc. CAD (OTC:HMPPF) PUF Ventures Inc. CAD (OTCPK:PUFXF) Liberty Leaf Holdings CAD (OTCQB:LIBFF) Canada House Welln

Top 10 Medical Stocks For 2019: iShares MSCI Japan (EWJ)

Advisors' Opinion:
  • [By Zacks]

    iShares MSCI Japan ETF (NYSE: EWJ)

    This fund is suitable for investors looking for broad-based exposure to the Japanese economy. It seeks to invest in large-cap companies.

  • [By Logan Wallace]

    Cookson Peirce & Co. Inc. acquired a new stake in iShares MSCI Japan ETF (NYSEARCA:EWJ) during the first quarter, according to its most recent 13F filing with the SEC. The fund acquired 5,090 shares of the exchange traded fund’s stock, valued at approximately $309,000.

Top 10 Medical Stocks For 2019: Summit Hotel Properties, Inc.(INN)

Advisors' Opinion:
  • [By Shane Hupp]

    New York State Common Retirement Fund reduced its position in Summit Hotel Properties Inc (NYSE:INN) by 3.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 186,900 shares of the real estate investment trust’s stock after selling 6,700 shares during the period. New York State Common Retirement Fund owned about 0.18% of Summit Hotel Properties worth $2,544,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Innova (INN) is a proof-of-work (PoW) coin that uses the NeoScrypt hashing algorithm. It was first traded on October 19th, 2017. Innova’s total supply is 4,032,857 coins and its circulating supply is 3,282,857 coins. Innova’s official website is innovacoin.info. Innova’s official Twitter account is @InnovaCoin.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Summit Hotel Properties (INN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks For 2019: Topdanmark A/S (TOP)

Advisors' Opinion:
  • [By Logan Wallace]

    TopCoin (CURRENCY:TOP) traded down 15.4% against the dollar during the 1-day period ending at 7:00 AM E.T. on June 21st. During the last seven days, TopCoin has traded up 4% against the dollar. TopCoin has a market cap of $0.00 and approximately $123.00 worth of TopCoin was traded on exchanges in the last day. One TopCoin coin can currently be bought for about $0.0010 or 0.00000015 BTC on popular exchanges.

Top 10 Medical Stocks For 2019: The Hanover Insurance Group, Inc.(THG)

Advisors' Opinion:
  • [By Max Byerly]

    The Hanover Insurance Group (NYSE:THG) was upgraded by stock analysts at Keefe, Bruyette & Woods from a “market perform” rating to an “outperform” rating in a research report issued on Friday, Marketbeat Ratings reports.

  • [By Joseph Griffin]

    Goelzer Investment Management Inc. reduced its holdings in shares of The Hanover Insurance Group, Inc. (NYSE:THG) by 3.7% during the 1st quarter, HoldingsChannel reports. The fund owned 40,309 shares of the insurance provider’s stock after selling 1,563 shares during the period. Goelzer Investment Management Inc.’s holdings in The Hanover Insurance Group were worth $4,752,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Teacher Retirement System of Texas cut its holdings in The Hanover Insurance Group, Inc. (NYSE:THG) by 36.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,373 shares of the insurance provider’s stock after selling 5,283 shares during the quarter. Teacher Retirement System of Texas’ holdings in The Hanover Insurance Group were worth $1,105,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Logan Wallace]

    Scout Investments Inc. acquired a new position in shares of The Hanover Insurance Group, Inc. (NYSE:THG) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 174,629 shares of the insurance provider’s stock, valued at approximately $20,587,000. Scout Investments Inc. owned about 0.41% of The Hanover Insurance Group at the end of the most recent quarter.

Top 10 Medical Stocks For 2019: Cliffs Natural Resources Inc.(CLF)

Advisors' Opinion:
  • [By Lisa Levin] Gainers AGM Group Holdings Inc. (NASDAQ: AGMH) shares climbed 30.3 percent to $11.05 after climbing 34.60 percent on Thursday. Limelight Networks, Inc. (NASDAQ: LLNW) jumped 21.2 percent to $4.9699 following a first-quarter earnings beat. The company also raised its fiscal 2018 estimates. Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) shares climbed 18.8 percent to $7.89 after reporting strong Q1 earnings. Farmers Capital Bank Corp (NASDAQ: FFKT) gained 15.4 percent to $48.75. WesBanco Inc (NASDAQ: WSBC) announced an agreement and plan of merger with Farmers Capital Bank Corporation. TransUnion (NYSE: TRU) climbed 10.2 percent to $66.76 after the company posted upbeat Q1 results and issued a strong forecast for the second quarter. TransUnion announced plans to acquire Callcredit. Myomo, Inc. (NYSE: MYO) shares gained 9.2 percent to $3.9299 after rising 8.11 percent on Thursday. Pinnacle Foods Inc (NYSE: PF) gained 8.8 percent to $60.04 after a 13-D filing from Jana Partners showed an increased stake in the comapny, from 1.42 million shares at the end of last quarter to 10.83 million shares, or a 9.3-percent stake. Associated Banc-Corp (NYSE: ASB) shares climbed 8.8 percent to $26.70 following upbeat Q1 earnings. OFG Bancorp (NYSE: OFG) gained 8.5 percent to $12.80 after reporting Q1 results. Cleveland-Cliffs Inc. (NYSE: CLF) climbed 7.5 percent to $7.73 following Q1 results. Seaspan Corporation (NYSE: SSW) shares climbed 6.7 percent to $7.50. Deutsche Bank upgraded Seaspan from Hold to Buy. General Electric Company (NYSE: GE) shares rose 4.6 percent to $14.63 after the company reported better-than-expected earnings for its first quarter. Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) rose 4.3 percent to $47.80. Biogen and Ionis have expanded their strategic collaboration to develop drug candidates for a broad range of neurological diseases.

    Check out these big penny stock gainers and losers

  • [By Stephan Byrd]

    Hudbay Minerals (NYSE: HBM) and Cleveland-Cliffs (NYSE:CLF) are both basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, dividends, risk and institutional ownership.

  • [By Rich Smith]

    Has there ever been a more surprising turnaround story than Cleveland-Cliffs (NYSE:CLF)?

    Once a bifurcated coal and iron miner known as Cliffs Natural Resources, folks began writing Cleveland-Cliffs' obituary in 2012 after President Obama was elected to his second term -- an apparent death knell to anyone involved in the coal industry. Three years later, the predictions seemed to be coming true, and analysts opined about whether Cleveland-Cliffs could even survive to the end of Obama's term. Within only a few short months, the stock would bottom out. But fast-forward a few years years, and what do we see today?

Top 10 Medical Stocks For 2019: Equinix Inc.(EQIX)

Advisors' Opinion:
  • [By Beth McKenna]

    Equinix (NASDAQ:EQIX) reported robust first-quarter 2018 financial results after the market close on Wednesday.�

    Shares closed down 6.1% on Thursday, which we can probably attribute to the company revising slightly downward its full-year 2018 adjusted funds from operations (AFFO) outlook, as we'll get to in a moment. (AFFO is a�closely watched metric for companies organized as real estate investment trusts, or REITs. It's akin to "earnings" for REITs.)�

  • [By Stephan Byrd]

    Credit Suisse Group set a $525.00 price objective on Equinix (NASDAQ:EQIX) in a research report report published on Friday. The firm currently has a buy rating on the financial services provider’s stock.

  • [By Matthew Frankel]

    Equinix (NASDAQ:EQIX) is the largest operator of data centers in the world, with more than 9,800 companies utilizing its properties. The company provides the facility, power, security, and cooling equipment for its customers, and they supply their own servers and networking equipment.

  • [By Lee Jackson]

    This is one of the larger cap companies in the data center arena and a top play for more conservative accounts. Equinix Inc. (NASDAQ: EQIX) provides data center services to protect and connect the information assets for the enterprises, financial services companies, and content and network providers primarily in the Americas, Europe, the Middle East, Africa and the Asia-Pacific.

  • [By Stephan Byrd]

    US Bancorp DE boosted its holdings in Equinix (NASDAQ:EQIX) by 12.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,159 shares of the financial services provider’s stock after purchasing an additional 920 shares during the quarter. US Bancorp DE’s holdings in Equinix were worth $3,411,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Medical Stocks For 2019: Bank of Nova Scotia (BNS)

Advisors' Opinion:
  • [By Motley Fool Staff]

    Bank of Nova Scotia (NYSE:BNS)Q2 2018 Earnings Conference CallMay 29, 2018, 8:00 a.m. ET

    Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

    Adam Borgatti -- Vice President, Investor Relations

  • [By Lisa Levin] Companies Reporting Before The Bell Booz Allen Hamilton Holding Corporation (NYSE: BAH) is estimated to report quarterly earnings at $0.46 per share on revenue of $1.67 billion. Momo Inc. (NASDAQ: MOMO) is projected to report quarterly earnings at $0.5 per share on revenue of $396.17 million. Multi-Color Corporation (NASDAQ: LABL) is expected to report quarterly earnings at $1.06 per share on revenue of $424.96 million. American Woodmark Corporation (NASDAQ: AMWD) is estimated to report quarterly earnings at $1.15 per share on revenue of $382.4 million. The Bank of Nova Scotia (NYSE: BNS) is projected to report quarterly earnings at $1.32 per share on revenue of $5.46 billion. Jianpu Technology Inc. (NYSE: JT) is expected to report quarterly loss at $0.04 per share on revenue of $47.51 million. Trans World Entertainment Corporation (NASDAQ: TWMC) is estimated to report earnings for its first quarter. Advanced Drainage Systems, Inc. (NYSE: WMS) is estimated to report quarterly loss at $0.06 per share on revenue of $249.44 million. Quotient Limited (NASDAQ: QTNT) is expected to report quarterly loss at $0.48 per share on revenue of $5.73 million. Elbit Systems Ltd. (NASDAQ: ESLT) is projected to report earnings for its first quarter. Evogene Ltd. (NASDAQ: EVGN) is expected to report earnings for its first quarter.

     

  • [By Ethan Ryder]

    Bank of Nova Scotia (NYSE:BNS) (TSE:BNS) has earned an average rating of “Hold” from the eleven ratings firms that are covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $94.00.

  • [By Ethan Ryder]

    Bank of Nova Scotia (TSE:BNS) (NYSE:BNS) – Stock analysts at Cormark raised their Q1 2019 earnings per share estimates for shares of Bank of Nova Scotia in a research note issued to investors on Tuesday, May 29th. Cormark analyst M. Grauman now forecasts that the bank will post earnings of $1.83 per share for the quarter, up from their prior forecast of $1.82. Cormark also issued estimates for Bank of Nova Scotia’s Q2 2019 earnings at $1.83 EPS, Q3 2019 earnings at $1.97 EPS and Q4 2019 earnings at $1.96 EPS.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Bank of Nova Scotia (BNS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Friday, July 13, 2018

Bed Bath & Beyond Makeover Not Sitting Well With Customers

The image makeover that was supposed to save Bed Bath & Beyond (NASDAQ:BBBY) instead seems to be keeping customers away. The home furnishings retailer reported its 10th consecutive quarter of falling same-store sales even though first-quarter earnings beat analyst expectations, and revenues were largely in line with forecasts.

Its once ubiquitous blue-and-white 20%-off coupons no longer hold the same power to draw in customers as they once did, with the retailer noting that although the value of the coupons increased in the period, their volume was down. People who did use them were using them to purchase more goods, but fewer customers were redeeming them.

CFO Robyn D'Elia did point out that more people were joining its Beyond+ member loyalty program, which would cause fewer people to need to use coupons since those members get 20% off purchases automatically, online and in store. However, fewer customers are visiting its stores, and they were making fewer purchases as the number of transactions declined.

Woman looking at bedding display

Image source: Getty Images.

Failure on display

Bed Bath & Beyond had the idea that if it carried less stuff�that you could actually buy in its stores but made the stores more of a display showcase for what you could buy online, it would entice customers to visit the website and make purchases there. Although there is some indication that could be happening -- the retailer said its "customer-facing digital channels" saw strong sales -- the overall anemic growth in total sales of just 0.4% indicates the reinvention of the stores is not having the intended effect.

The problem is Bed Bath & Beyond is under assault from competitors all around it, like Walmart�and Target in the brick-and-mortar realm, and Amazon.com�and Wayfair in the digital. The pricing pressure it's under to maintain a competitive position to its rivals is taking a toll on margins, which contracted again in the quarter.

This also comes as it has invested considerable sums in upgrading its online presence after years of neglect, but it may not have the financial resources available to continue fending off the inroads its competition is making.

The future of online shopping

Earlier this year, Walmart acquired augmented reality start-up Spatialand for an undisclosed sum to help reimagine at-home shopping, which followed William-Sonoma's purchase last November of 3D imaging and AR specialist Outward for $112 million to develop visual merchandising of its products.

Bed Bath & Beyond says it is in the furniture business and is working to convey that message to customers, but if it's going to keep pace with the next phase of where retailing may be heading, it's going to require more substantial investment on the retailer's part.

That suggests the 2020 timeline the home furnishings store has for turning itself around is likely going to be pushed even further out into the future. Simply putting more pillowcases on display in its store isn't going to push the envelope far enough.

Not a good value

Although Bed Bath & Beyond trades at a significant discount, there's no indication that its plan for correcting course will actually work. It's certainly not having an impact now -- earnings beat analysts' expectations by $0.02, but they were still down 40% year over year. And they only were able to beat Wall Street's numbers, because the retailer continues to buy back significant amounts of its own stock. Had the share count been left alone, earnings would have merely been in line and down by an even greater percentage from last year.

Bed Bath & Beyond does need to meet the changing ways consumers shop but having waited so long to make those investments, it's likely lost the chance to benefit from the bankruptcy of direct rivals like Linens N Things so many years ago.

Now, mass-merchandisers like Walmart have filled the gap, as have other rivals. There isn't enough incentive in paying $29 a year to get that 20% off coupon you used to get in your mailbox for free to generate enough sales to make Bed Bath & Beyond's turnaround a reality.

Thursday, July 12, 2018

3 Tips for Small-Business Owners Competing With Chains

When you run a small business that competes with national chains, it's not enough to be locally owned. That might get the people in your community to stop by and wish you luck. But in most cases, it won't be enough to win sustainable business.

Making your small business stand out requires doing things that larger competitors either don't or can't do. That takes a commitment from you to being more than just a business owner -- you have to be part of the community and part of your customers' lives.

A customer hands over a credit card.

It's important to build a connection with your customers. Image source: Getty Images.

1. Offer the best service

When I ran a very large local toy, hobby, and model-train store, I made sure my staff treated everyone like a big spender. That meant that the older gentleman who required two hours of help to buy $1.43 in collectible stamps got the same level of attention as the person who casually dropped $10,000 on high-end model trains.

It also meant that we sometimes put in a lot of effort educating people on certain bigger-ticket items only to see them leave the store, maybe never to return (and likely having purchased their item for less online). That was something we had to accept, but having an overall commitment to customer service won us loyalty and referrals.

2. Know your audience

Our toy store had regulars whom we knew by name and by interest. That made it possible to go the extra mile in not just greeting customers, but also in being able to show them whatever new find had come in that they might be interested in.

It was also important to make new customers feel like part of the family. That could mean offering a tour, playing a game with someone, or showing their young child one of the store's interactive play areas while getting mom or dad a coffee or soda.

3. Go above and beyond

A major chain generally can't change its decision about opening on Easter because it has a lot of regular customers with nothing to do that day. At the toy store, we opened by request that day with just me and one other volunteer working. We bought doughnuts, gave away coffee, and made some of our customers who either didn't have family or were away from theirs feel welcome.

There were countless times we opened early or stayed open late to accommodate customers. We also held regular customer appreciation barbecues, rented a cotton candy machine (a sticky mistake, albeit a popular one), and bought ice pops on hot days.

We delivered new releases to sick customers and set aside things for people while they were traveling. Essentially, if there was something we could do, we did it.

Be the best you can

In general, most smaller stores or service providers can't compete with chains when it comes to price. Even as a very large independent toy store, we did not have the pricing power of our retail rivals. And in some cases, we could not even get some popular items.

Despite that, we listened to our customers. We could not, for example, purchase the popular children's games Candyland or Chutes & Ladders because their manufacturer made little else we wanted, so we could not hit order minimums.

Since our customers wanted those games (even though we sold much better alternatives), we simply waited for the big chains to put them on sale and bought them by the vanload. We didn't even mark them up. They just went on the shelf as a courtesy because our audience wanted them.

As a small-business owner, you can compete by being better and having a deep personal connection. That's not in any way easy, but it's possible. And it's how you can build an audience even when competing with much bigger rivals.

Wednesday, July 11, 2018

Moon Capital Management LLC Has $4.10 Million Position in AerCap Holdings (AER)

Moon Capital Management LLC increased its stake in AerCap Holdings (NYSE:AER) by 8.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 75,715 shares of the financial services provider’s stock after buying an additional 5,691 shares during the quarter. AerCap comprises approximately 4.4% of Moon Capital Management LLC’s holdings, making the stock its 6th largest holding. Moon Capital Management LLC’s holdings in AerCap were worth $4,100,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of AER. Schwab Charles Investment Management Inc. lifted its position in AerCap by 5.6% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 68,122 shares of the financial services provider’s stock worth $3,584,000 after buying an additional 3,608 shares during the last quarter. AXA lifted its position in shares of AerCap by 96.0% during the fourth quarter. AXA now owns 17,420 shares of the financial services provider’s stock worth $917,000 after purchasing an additional 8,531 shares during the last quarter. Amundi Pioneer Asset Management Inc. bought a new stake in shares of AerCap during the fourth quarter worth $31,769,000. MML Investors Services LLC lifted its position in shares of AerCap by 43.8% during the fourth quarter. MML Investors Services LLC now owns 8,142 shares of the financial services provider’s stock worth $428,000 after purchasing an additional 2,479 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec lifted its position in shares of AerCap by 91.0% during the fourth quarter. Caisse DE Depot ET Placement DU Quebec now owns 94,199 shares of the financial services provider’s stock worth $4,956,000 after purchasing an additional 44,878 shares during the last quarter. Institutional investors own 83.59% of the company’s stock.

Get AerCap alerts:

Several analysts have recently weighed in on AER shares. Zacks Investment Research upgraded AerCap from a “hold” rating to a “buy” rating and set a $62.00 target price for the company in a research report on Monday, May 28th. Morgan Stanley lifted their target price on AerCap from $49.00 to $52.00 and gave the stock an “underweight” rating in a research report on Thursday, April 12th. Cowen reiterated an “outperform” rating and set a $60.00 target price (up from $58.00) on shares of AerCap in a research report on Friday, May 4th. ValuEngine downgraded AerCap from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, May 2nd. Finally, Deutsche Bank lifted their target price on AerCap from $68.00 to $71.00 and gave the stock a “buy” rating in a research report on Friday, May 4th. One research analyst has rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the stock. AerCap currently has a consensus rating of “Buy” and an average target price of $61.44.

Shares of AerCap stock traded up $0.61 during trading on Monday, hitting $55.20. 77,861 shares of the stock traded hands, compared to its average volume of 875,255. The firm has a market cap of $8.63 billion, a P/E ratio of 8.67, a P/E/G ratio of 0.71 and a beta of 1.82. The company has a current ratio of 0.60, a quick ratio of 0.60 and a debt-to-equity ratio of 3.34. AerCap Holdings has a 52-week low of $46.53 and a 52-week high of $56.26.

AerCap (NYSE:AER) last announced its quarterly earnings results on Thursday, May 3rd. The financial services provider reported $1.72 EPS for the quarter, beating the consensus estimate of $1.54 by $0.18. The firm had revenue of $1.22 billion for the quarter, compared to analyst estimates of $1.22 billion. AerCap had a return on equity of 12.54% and a net margin of 21.52%. The business’s revenue for the quarter was down 1.4% on a year-over-year basis. During the same quarter last year, the firm posted $1.48 earnings per share. analysts forecast that AerCap Holdings will post 6.42 earnings per share for the current year.

AerCap Company Profile

AerCap Holdings N.V., an aircraft leasing company, engages in the lease, financing, sale, and management of commercial aircraft and engines in Mainland China, Hong Kong, Macau, the United States, Ireland, and internationally. The company provides aircraft asset management services, including remarketing aircraft; collecting rental and maintenance rent payments, monitoring aircraft maintenance, monitoring and enforcing contract compliance, and accepting delivery and redelivery of aircraft; and conducting ongoing lessee financial performance reviews.

Want to see what other hedge funds are holding AER? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AerCap Holdings (NYSE:AER).

Institutional Ownership by Quarter for AerCap (NYSE:AER)

Saturday, July 7, 2018

REBL (REBL) Achieves Market Capitalization of $6.82 Million

REBL (CURRENCY:REBL) traded 2.1% higher against the US dollar during the one day period ending at 8:00 AM E.T. on July 7th. One REBL token can currently be purchased for about $0.0400 or 0.00000608 BTC on major cryptocurrency exchanges including CoinFalcon, Token Store, EtherDelta (ForkDelta) and Bit-Z. During the last week, REBL has traded 4.1% higher against the US dollar. REBL has a market cap of $6.82 million and approximately $1.29 million worth of REBL was traded on exchanges in the last day.

Here is how similar cryptocurrencies have performed during the last day:

Get REBL alerts: XRP (XRP) traded 0.7% lower against the dollar and now trades at $0.47 or 0.00007181 BTC. Stellar (XLM) traded 0.4% higher against the dollar and now trades at $0.20 or 0.00003099 BTC. IOTA (MIOTA) traded 1% lower against the dollar and now trades at $1.07 or 0.00016297 BTC. Tether (USDT) traded down 0.1% against the dollar and now trades at $1.00 or 0.00015234 BTC. NEO (NEO) traded down 3.1% against the dollar and now trades at $37.29 or 0.00565997 BTC. TRON (TRX) traded 0.3% higher against the dollar and now trades at $0.0366 or 0.00000556 BTC. Binance Coin (BNB) traded 5.9% higher against the dollar and now trades at $14.26 or 0.00216377 BTC. VeChain (VET) traded up 1.8% against the dollar and now trades at $2.49 or 0.00037803 BTC. Ontology (ONT) traded down 1% against the dollar and now trades at $4.66 or 0.00070675 BTC. Zilliqa (ZIL) traded up 0.2% against the dollar and now trades at $0.0823 or 0.00001250 BTC.

REBL Token Profile

REBL was first traded on November 4th, 2017. REBL’s total supply is 326,480,305 tokens and its circulating supply is 170,376,386 tokens. The official website for REBL is www.rebellious.io. REBL’s official Twitter account is @RebelliousCoin. The Reddit community for REBL is /r/RebelliousCoin and the currency’s Github account can be viewed here.

Buying and Selling REBL

REBL can be traded on the following cryptocurrency exchanges: Bit-Z, EtherDelta (ForkDelta), CoinFalcon and Token Store. It is usually not presently possible to purchase alternative cryptocurrencies such as REBL directly using U.S. dollars. Investors seeking to trade REBL should first purchase Bitcoin or Ethereum using an exchange that deals in U.S. dollars such as Coinbase, Changelly or Gemini. Investors can then use their newly-acquired Bitcoin or Ethereum to purchase REBL using one of the exchanges listed above.

new TradingView.widget({ “height”: 400, “width”: 650, “symbol”: “REBLUSD”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Friday, July 6, 2018

Crude Palm Oil prices to trade sideways to positive: Angel Commodities


Angel Commodities' report on Crude Palm oil


MCX CPO continues to trade lower this week and closed lower for fifth successive session due tracking weak palm oil in Malaysia and lower tariff value for July. However, prices have been in a range due to weaker rupees and steady domestic demand.� The government has slashed the base import price of CPO and RBD Palmolein by $26 to $618 per ton and $27 to $646 per ton respectively.

Outlook
CPO futures may trade sideways to positive on bargain buying and improved prices in international prices. However higher domestic stocks and steady domestic demand from the stockists may keep the prices sideways.

For all commodities report, click here


Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions. Read More First Published on Jul 5, 2018 11:39 am

Wednesday, July 4, 2018

Zacks Investment Research Upgrades Lamb Weston (LW) to Buy

Lamb Weston (NYSE:LW) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday. The brokerage currently has a $76.00 price target on the specialty retailer’s stock. Zacks Investment Research‘s price target suggests a potential upside of 11.16% from the stock’s current price.

According to Zacks, “Lamb Weston has surpassed the industry in the past six months. The company has been gaining from its robust LTO innovations, which drove nearly half the volume growth of Lamb Weston’s significant Global segment in the third-quarter fiscal 2018. During the quarter, both top and bottom lines grew year over year and topped estimates for the sixth straight time. While earnings gained from lower tax rate, higher operating income and equity method investment earnings, sales were backed by strong volumes and pricing. Management expects price/mix to grow in fiscal 2018, which led to a raised sales view. However, transportation, warehousing and commodity costs are expected to increase. Also, raw potato prices are expected to rise in low to mid single-digit range. These factors, along with an anticipated rise in SG&A costs may hurt margins. Near-term issues in the foodservice unit are also a worry.”

Get Lamb Weston alerts:

LW has been the topic of a number of other reports. ValuEngine raised Lamb Weston from a “hold” rating to a “buy” rating in a research report on Thursday, June 21st. Bank of America upped their price target on Lamb Weston from $65.00 to $70.00 and gave the company a “buy” rating in a report on Tuesday, June 19th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $71.00 price target on shares of Lamb Weston in a report on Wednesday, June 6th. Morgan Stanley upped their price target on Lamb Weston from $61.00 to $64.00 and gave the company an “equal weight” rating in a report on Friday, April 6th. Finally, Vertical Group began coverage on Lamb Weston in a report on Tuesday, May 22nd. They issued a “sell” rating and a $56.00 target price for the company. Two analysts have rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the stock. Lamb Weston has an average rating of “Hold” and an average target price of $66.83.

Shares of Lamb Weston stock traded up $0.38 on Wednesday, reaching $68.37. 514,488 shares of the company traded hands, compared to its average volume of 1,042,591. The company has a quick ratio of 0.63, a current ratio of 1.72 and a debt-to-equity ratio of -5.98. Lamb Weston has a 52 week low of $42.58 and a 52 week high of $69.55. The company has a market capitalization of $9.94 billion, a P/E ratio of 29.47, a P/E/G ratio of 1.84 and a beta of 0.53.

Lamb Weston (NYSE:LW) last announced its earnings results on Thursday, April 5th. The specialty retailer reported $0.91 EPS for the quarter, beating the consensus estimate of $0.80 by $0.11. Lamb Weston had a negative return on equity of 69.53% and a net margin of 11.75%. The business had revenue of $863.40 million for the quarter, compared to the consensus estimate of $813.81 million. During the same period last year, the business posted $0.59 EPS. The company’s revenue was up 12.3% on a year-over-year basis. equities analysts expect that Lamb Weston will post 2.62 EPS for the current fiscal year.

Large investors have recently modified their holdings of the stock. Goldman Sachs Group Inc. raised its holdings in shares of Lamb Weston by 0.9% during the fourth quarter. Goldman Sachs Group Inc. now owns 939,845 shares of the specialty retailer’s stock valued at $53,054,000 after purchasing an additional 8,769 shares during the last quarter. GSA Capital Partners LLP raised its stake in shares of Lamb Weston by 29.7% in the first quarter. GSA Capital Partners LLP now owns 37,078 shares of the specialty retailer’s stock valued at $2,159,000 after acquiring an additional 8,494 shares during the period. Driehaus Capital Management LLC increased its stake in Lamb Weston by 30.9% in the 4th quarter. Driehaus Capital Management LLC now owns 32,946 shares of the specialty retailer’s stock worth $1,860,000 after buying an additional 7,774 shares during the period. MetLife Investment Advisors LLC purchased a new stake in Lamb Weston in the 4th quarter valued at about $5,221,000. Finally, QS Investors LLC lifted its position in shares of Lamb Weston by 10.9% in the 4th quarter. QS Investors LLC now owns 10,101 shares of the specialty retailer’s stock worth $570,000 after acquiring an additional 994 shares during the period. Institutional investors own 79.52% of the company’s stock.

Lamb Weston Company Profile

Lamb Weston Holdings, Inc produces and markets value-added frozen potato products worldwide. It operates through four segments: Global, Foodservice, Retail, and Other. The company offers frozen potatoes, sweet potatoes, and appetizers under the Lamb Weston brand name, as well as various customer labels.

Get a free copy of the Zacks research report on Lamb Weston (LW)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Lamb Weston (NYSE:LW)

Sunday, June 24, 2018

$11.00 Million in Sales Expected for Hannon Armstrong Sustnbl Infrstr Cap Inc (HASI) This Quarter

Wall Street analysts expect Hannon Armstrong Sustnbl Infrstr Cap Inc (NYSE:HASI) to announce $11.00 million in sales for the current fiscal quarter, according to Zacks. Four analysts have made estimates for Hannon Armstrong Sustnbl Infrstr Cap’s earnings, with the lowest sales estimate coming in at $10.03 million and the highest estimate coming in at $11.90 million. Hannon Armstrong Sustnbl Infrstr Cap posted sales of $12.91 million in the same quarter last year, which suggests a negative year-over-year growth rate of 14.8%. The firm is expected to issue its next earnings results on Wednesday, August 1st.

On average, analysts expect that Hannon Armstrong Sustnbl Infrstr Cap will report full-year sales of $46.05 million for the current financial year, with estimates ranging from $42.92 million to $51.00 million. For the next year, analysts forecast that the business will report sales of $50.01 million per share, with estimates ranging from $41.60 million to $57.00 million. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side analysts that that provide coverage for Hannon Armstrong Sustnbl Infrstr Cap.

Get Hannon Armstrong Sustnbl Infrstr Cap alerts:

Hannon Armstrong Sustnbl Infrstr Cap (NYSE:HASI) last posted its earnings results on Thursday, May 3rd. The real estate investment trust reported $0.27 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.31 by ($0.04). The business had revenue of $9.20 million for the quarter, compared to analyst estimates of $10.24 million. Hannon Armstrong Sustnbl Infrstr Cap had a return on equity of 8.40% and a net margin of 20.45%.

HASI has been the subject of a number of research analyst reports. Cowen set a $28.00 target price on shares of Hannon Armstrong Sustnbl Infrstr Cap and gave the stock a “buy” rating in a research report on Thursday, February 22nd. B. Riley set a $26.00 target price on shares of Hannon Armstrong Sustnbl Infrstr Cap and gave the stock a “buy” rating in a research report on Thursday, February 22nd. UBS Group initiated coverage on shares of Hannon Armstrong Sustnbl Infrstr Cap in a research report on Thursday, March 15th. They set a “buy” rating and a $21.00 target price for the company. Zacks Investment Research raised shares of Hannon Armstrong Sustnbl Infrstr Cap from a “sell” rating to a “hold” rating in a research report on Thursday, May 10th. Finally, Robert W. Baird reissued an “outperform” rating and set a $26.00 target price (down previously from $30.00) on shares of Hannon Armstrong Sustnbl Infrstr Cap in a research report on Thursday, February 22nd. One analyst has rated the stock with a sell rating, three have issued a hold rating and eight have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $25.89.

In other news, Director Steven G. Osgood acquired 5,000 shares of the stock in a transaction on Monday, June 4th. The stock was bought at an average price of $18.28 per share, with a total value of $91,400.00. Following the completion of the transaction, the director now directly owns 28,281 shares of the company’s stock, valued at $516,976.68. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jeffrey Eckel acquired 1,630 shares of the stock in a transaction on Wednesday, May 9th. The stock was purchased at an average cost of $18.95 per share, with a total value of $30,888.50. Following the transaction, the insider now directly owns 877,270 shares of the company’s stock, valued at $16,624,266.50. The disclosure for this purchase can be found here. Insiders acquired 22,435 shares of company stock valued at $411,277 in the last ninety days. 5.30% of the stock is owned by corporate insiders.

Several hedge funds have recently added to or reduced their stakes in HASI. Handelsbanken Fonder AB grew its position in shares of Hannon Armstrong Sustnbl Infrstr Cap by 130.1% during the first quarter. Handelsbanken Fonder AB now owns 944,483 shares of the real estate investment trust’s stock worth $18,417,000 after buying an additional 534,083 shares in the last quarter. Teachers Advisors LLC grew its position in shares of Hannon Armstrong Sustnbl Infrstr Cap by 386.2% during the fourth quarter. Teachers Advisors LLC now owns 426,796 shares of the real estate investment trust’s stock worth $10,269,000 after buying an additional 339,010 shares in the last quarter. American Assets Capital Advisers LLC bought a new position in Hannon Armstrong Sustnbl Infrstr Cap during the first quarter worth $6,068,000. Amundi Pioneer Asset Management Inc. bought a new position in Hannon Armstrong Sustnbl Infrstr Cap during the fourth quarter worth $7,401,000. Finally, Van ECK Associates Corp lifted its stake in Hannon Armstrong Sustnbl Infrstr Cap by 15.5% during the first quarter. Van ECK Associates Corp now owns 1,379,890 shares of the real estate investment trust’s stock worth $26,908,000 after purchasing an additional 184,817 shares during the last quarter. 71.80% of the stock is owned by institutional investors and hedge funds.

HASI traded down $0.02 on Tuesday, reaching $19.02. 5,147 shares of the company’s stock were exchanged, compared to its average volume of 380,416. The company has a market cap of $993.15 million, a PE ratio of 18.03, a price-to-earnings-growth ratio of 2.59 and a beta of 0.83. Hannon Armstrong Sustnbl Infrstr Cap has a twelve month low of $17.33 and a twelve month high of $25.28. The company has a debt-to-equity ratio of 2.28, a quick ratio of 38.94 and a current ratio of 38.94.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 12th. Shareholders of record on Thursday, July 5th will be given a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 6.94%. The ex-dividend date of this dividend is Tuesday, July 3rd. Hannon Armstrong Sustnbl Infrstr Cap’s dividend payout ratio (DPR) is 125.71%.

About Hannon Armstrong Sustnbl Infrstr Cap

Hannon Armstrong Sustainable Infrastructure Capital, Inc provides capital and services to the energy efficiency, renewable energy, and other sustainable infrastructure markets in the United States. The company's projects include energy efficiency projects that reduce a building's or facility's energy usage or cost through enhancing or installing various building components, including heating, ventilation, and air conditioning systems, as well as lighting, energy controls, roofs, windows, building shells, and/or combined heat and power systems.

Get a free copy of the Zacks research report on Hannon Armstrong Sustnbl Infrstr Cap (HASI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Wednesday, June 20, 2018

Gaia Inc (GAIA) Expected to Announce Earnings of -$0.42 Per Share

Wall Street analysts forecast that Gaia Inc (NASDAQ:GAIA) will report earnings per share (EPS) of ($0.42) for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Gaia’s earnings. Gaia also posted earnings of ($0.42) per share in the same quarter last year. The firm is scheduled to report its next earnings results on Monday, August 6th.

According to Zacks, analysts expect that Gaia will report full year earnings of ($1.65) per share for the current year, with EPS estimates ranging from ($1.75) to ($1.58). For the next fiscal year, analysts anticipate that the company will report earnings of ($1.21) per share, with EPS estimates ranging from ($1.37) to ($1.13). Zacks’ EPS averages are an average based on a survey of research analysts that follow Gaia.

Get Gaia alerts:

Gaia (NASDAQ:GAIA) last posted its quarterly earnings data on Monday, May 7th. The company reported ($0.39) earnings per share for the quarter, topping the consensus estimate of ($0.53) by $0.14. The firm had revenue of $9.62 million for the quarter, compared to analysts’ expectations of $9.41 million. Gaia had a negative return on equity of 26.84% and a negative net margin of 72.00%.

A number of research analysts recently commented on GAIA shares. B. Riley started coverage on Gaia in a research report on Monday, March 26th. They issued a “buy” rating and a $23.00 price target on the stock. Lake Street Capital restated a “buy” rating and issued a $20.00 price target (up previously from $17.00) on shares of Gaia in a research report on Tuesday, February 27th. Dougherty & Co started coverage on Gaia in a research report on Wednesday, March 28th. They issued a “buy” rating and a $22.00 price target on the stock. Roth Capital started coverage on Gaia in a research note on Friday, April 27th. They issued a “buy” rating and a $21.00 price objective on the stock. Finally, TheStreet raised Gaia from a “d+” rating to a “c-” rating in a research note on Monday, February 26th. Four investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $22.25.

Shares of NASDAQ GAIA opened at $20.90 on Wednesday. Gaia has a 52 week low of $10.35 and a 52 week high of $21.00. The firm has a market capitalization of $360.34 million, a P/E ratio of -13.31 and a beta of 0.82.

A number of large investors have recently added to or reduced their stakes in GAIA. BlackRock Inc. boosted its stake in Gaia by 0.9% in the fourth quarter. BlackRock Inc. now owns 776,008 shares of the company’s stock valued at $9,623,000 after buying an additional 6,882 shares in the last quarter. Suntrust Banks Inc. acquired a new stake in Gaia in the fourth quarter valued at about $136,000. Geode Capital Management LLC boosted its stake in Gaia by 35.1% in the fourth quarter. Geode Capital Management LLC now owns 138,771 shares of the company’s stock valued at $1,720,000 after buying an additional 36,047 shares in the last quarter. Deutsche Bank AG boosted its stake in Gaia by 14.1% in the fourth quarter. Deutsche Bank AG now owns 91,628 shares of the company’s stock valued at $1,134,000 after buying an additional 11,343 shares in the last quarter. Finally, Millennium Management LLC boosted its stake in Gaia by 82.8% in the fourth quarter. Millennium Management LLC now owns 55,656 shares of the company’s stock valued at $690,000 after buying an additional 25,202 shares in the last quarter. 41.85% of the stock is currently owned by institutional investors and hedge funds.

About Gaia

Gaia, Inc operates a digital video subscription service and online community that caters underserved subscribers worldwide. The company has a digital content library of approximately 8,000 titles available to its subscribers on Internet-connected devices. Its subscribers have access to a library of films, documentaries, interviews, yoga classes, transformation related content, and others for digital streaming.

Get a free copy of the Zacks research report on Gaia (GAIA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Gaia (NASDAQ:GAIA)

Monday, June 4, 2018

CNO Financial Group (CNO) Declares Dividend Increase – $0.10 Per Share

CNO Financial Group (NYSE:CNO) announced a quarterly dividend on Thursday, May 10th, Wall Street Journal reports. Stockholders of record on Monday, June 11th will be given a dividend of 0.10 per share by the financial services provider on Monday, June 25th. This represents a $0.40 annualized dividend and a dividend yield of 1.96%. The ex-dividend date of this dividend is Friday, June 8th. This is a boost from CNO Financial Group’s previous quarterly dividend of $0.09.

CNO Financial Group has raised its dividend payment by an average of 13.4% per year over the last three years and has increased its dividend every year for the last 5 years. CNO Financial Group has a payout ratio of 21.8% indicating that its dividend is sufficiently covered by earnings. Research analysts expect CNO Financial Group to earn $2.19 per share next year, which means the company should continue to be able to cover its $0.36 annual dividend with an expected future payout ratio of 16.4%.

Get CNO Financial Group alerts:

CNO Financial Group opened at $20.38 on Friday, MarketBeat reports. CNO Financial Group has a 52-week low of $19.37 and a 52-week high of $26.47. The firm has a market capitalization of $3.34 billion, a PE ratio of 10.09, a price-to-earnings-growth ratio of 0.99 and a beta of 1.16. The company has a quick ratio of 0.15, a current ratio of 0.15 and a debt-to-equity ratio of 0.55.

CNO Financial Group (NYSE:CNO) last released its quarterly earnings data on Wednesday, April 25th. The financial services provider reported $0.44 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.44. CNO Financial Group had a net margin of 4.67% and a return on equity of 6.92%. The company had revenue of $1.01 billion during the quarter, compared to analyst estimates of $1.01 billion. research analysts anticipate that CNO Financial Group will post 2.02 EPS for the current fiscal year.

Several equities research analysts have recently issued reports on the stock. Morgan Stanley reissued an “equal weight” rating on shares of CNO Financial Group in a research report on Thursday. Zacks Investment Research lowered shares of CNO Financial Group from a “buy” rating to a “hold” rating in a research report on Friday, April 6th. ValuEngine lowered shares of CNO Financial Group from a “hold” rating to a “sell” rating in a research report on Wednesday, May 2nd. Wells Fargo & Co set a $23.00 price objective on shares of CNO Financial Group and gave the stock a “hold” rating in a research report on Wednesday, April 25th. Finally, William Blair assumed coverage on shares of CNO Financial Group in a research report on Monday, March 12th. They issued an “outperform” rating for the company. Two investment analysts have rated the stock with a sell rating, four have given a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $24.00.

About CNO Financial Group

CNO Financial Group, Inc, through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, and other insurance products for senior and middle-income markets in the United States. It operates through Bankers Life, Washington National, Colonial Penn, and Long-Term Care in Run Off segments.

Dividend History for CNO Financial Group (NYSE:CNO)

Tuesday, May 29, 2018

Analysts Anticipate Array Biopharma Inc (ARRY) to Announce -$0.25 EPS

Equities analysts expect Array Biopharma Inc (NASDAQ:ARRY) to post earnings of ($0.25) per share for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for Array Biopharma’s earnings, with estimates ranging from ($0.35) to ($0.16). Array Biopharma posted earnings of ($0.17) per share in the same quarter last year, which indicates a negative year-over-year growth rate of 47.1%. The firm is scheduled to announce its next earnings report on Wednesday, August 8th.

According to Zacks, analysts expect that Array Biopharma will report full-year earnings of ($0.76) per share for the current fiscal year, with EPS estimates ranging from ($0.85) to ($0.65). For the next year, analysts anticipate that the business will report earnings of ($0.64) per share, with EPS estimates ranging from ($1.16) to ($0.28). Zacks’ EPS calculations are a mean average based on a survey of research firms that that provide coverage for Array Biopharma.

Get Array Biopharma alerts:

Array Biopharma (NASDAQ:ARRY) last posted its earnings results on Wednesday, May 9th. The biopharmaceutical company reported ($0.11) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.22) by $0.11. Array Biopharma had a negative return on equity of 96.65% and a negative net margin of 72.33%. The business had revenue of $66.37 million during the quarter, compared to analysts’ expectations of $28.81 million. During the same period in the previous year, the business earned ($0.21) earnings per share. The firm’s revenue was up 99.4% on a year-over-year basis.

Several equities analysts recently commented on the company. Stifel Nicolaus boosted their target price on Array Biopharma from $20.00 to $23.00 and gave the stock a “buy” rating in a research report on Wednesday, February 7th. BidaskClub upgraded Array Biopharma from a “sell” rating to a “hold” rating in a research report on Monday, May 14th. Zacks Investment Research cut Array Biopharma from a “buy” rating to a “hold” rating in a research report on Monday, May 14th. SunTrust Banks restated a “buy” rating and set a $20.00 target price on shares of Array Biopharma in a research report on Tuesday, February 6th. Finally, Leerink Swann boosted their target price on Array Biopharma from $19.00 to $20.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 7th. Two research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $18.00.

In other Array Biopharma news, Director Lunsen Gil J. Van sold 21,500 shares of Array Biopharma stock in a transaction dated Wednesday, March 21st. The stock was sold at an average price of $16.76, for a total transaction of $360,340.00. Following the completion of the sale, the director now owns 26,297 shares of the company’s stock, valued at $440,737.72. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Victor Sandor sold 156,016 shares of Array Biopharma stock in a transaction dated Friday, March 9th. The stock was sold at an average price of $17.71, for a total value of $2,763,043.36. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 229,205 shares of company stock valued at $3,913,585. Corporate insiders own 3.18% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Ladenburg Thalmann Financial Services Inc. lifted its stake in shares of Array Biopharma by 107.9% in the 1st quarter. Ladenburg Thalmann Financial Services Inc. now owns 8,614 shares of the biopharmaceutical company’s stock valued at $140,000 after acquiring an additional 4,470 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Array Biopharma by 70.9% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,244 shares of the biopharmaceutical company’s stock valued at $118,000 after acquiring an additional 3,834 shares during the last quarter. QS Investors LLC bought a new stake in shares of Array Biopharma in the 4th quarter valued at about $134,000. GSA Capital Partners LLP bought a new stake in shares of Array Biopharma in the 1st quarter valued at about $208,000. Finally, Royal Bank of Canada lifted its stake in shares of Array Biopharma by 266.7% in the 1st quarter. Royal Bank of Canada now owns 12,874 shares of the biopharmaceutical company’s stock valued at $211,000 after acquiring an additional 9,363 shares during the last quarter. 92.55% of the stock is owned by institutional investors.

Array Biopharma stock traded up $0.25 during midday trading on Wednesday, hitting $15.89. 1,305,354 shares of the company’s stock were exchanged, compared to its average volume of 2,500,259. Array Biopharma has a 52-week low of $7.15 and a 52-week high of $18.78. The company has a quick ratio of 5.73, a current ratio of 5.73 and a debt-to-equity ratio of 0.36. The stock has a market cap of $3.35 billion, a price-to-earnings ratio of -22.07 and a beta of 1.73.

Array Biopharma Company Profile

Array BioPharma Inc, a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific. The company's drugs in Phase III clinical trials include Binimetinib, Encorafenib, Selumetinib, and Ipatasertib/GDC-0068 for the treatment of cancer, as well as ASC08/Danoprevir to treat hepatitis C virus.

Get a free copy of the Zacks research report on Array Biopharma (ARRY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Array Biopharma (NASDAQ:ARRY)

Monday, May 28, 2018

JPMorgan Chase & Co. (JPM) Shares Bought by Pinnacle Financial Partners Inc.

Pinnacle Financial Partners Inc. grew its stake in JPMorgan Chase & Co. (NYSE:JPM) by 16.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 122,733 shares of the financial services provider’s stock after buying an additional 17,501 shares during the period. JPMorgan Chase & Co. accounts for 1.4% of Pinnacle Financial Partners Inc.’s investment portfolio, making the stock its 10th largest holding. Pinnacle Financial Partners Inc.’s holdings in JPMorgan Chase & Co. were worth $13,125,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of JPM. Stifel Financial Corp raised its position in JPMorgan Chase & Co. by 9,301.6% in the 3rd quarter. Stifel Financial Corp now owns 4,351,736 shares of the financial services provider’s stock valued at $415,662,000 after purchasing an additional 4,305,449 shares during the last quarter. Jennison Associates LLC raised its position in JPMorgan Chase & Co. by 11.7% in the 4th quarter. Jennison Associates LLC now owns 17,180,823 shares of the financial services provider’s stock valued at $1,837,317,000 after purchasing an additional 1,804,721 shares during the last quarter. Atlantic Trust Group LLC raised its position in JPMorgan Chase & Co. by 62.6% in the 3rd quarter. Atlantic Trust Group LLC now owns 4,398,186 shares of the financial services provider’s stock valued at $420,070,000 after purchasing an additional 1,692,999 shares during the last quarter. Caxton Associates LP raised its position in JPMorgan Chase & Co. by 18,506.8% in the 3rd quarter. Caxton Associates LP now owns 1,097,800 shares of the financial services provider’s stock valued at $104,851,000 after purchasing an additional 1,091,900 shares during the last quarter. Finally, CI Investments Inc. raised its position in JPMorgan Chase & Co. by 147.8% in the 4th quarter. CI Investments Inc. now owns 1,805,968 shares of the financial services provider’s stock valued at $193,130,000 after purchasing an additional 1,077,106 shares during the last quarter. Institutional investors and hedge funds own 72.18% of the company’s stock.

Get JPMorgan Chase & Co. alerts:

Shares of JPMorgan Chase & Co. opened at $110.66 on Monday, according to MarketBeat Ratings. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 1.19. The stock has a market capitalization of $379.78 billion, a PE ratio of 16.11, a P/E/G ratio of 1.83 and a beta of 1.24. JPMorgan Chase & Co. has a 52-week low of $81.64 and a 52-week high of $119.33.

JPMorgan Chase & Co. (NYSE:JPM) last announced its quarterly earnings results on Friday, April 13th. The financial services provider reported $2.37 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.28 by $0.09. The business had revenue of $27.90 billion during the quarter, compared to the consensus estimate of $27.73 billion. JPMorgan Chase & Co. had a net margin of 22.53% and a return on equity of 12.60%. The business’s revenue was up 12.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.65 EPS. equities research analysts forecast that JPMorgan Chase & Co. will post 9.05 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 31st. Stockholders of record on Friday, July 6th will be issued a $0.56 dividend. The ex-dividend date is Thursday, July 5th. This represents a $2.24 dividend on an annualized basis and a dividend yield of 2.02%. JPMorgan Chase & Co.’s dividend payout ratio is presently 32.61%.

Several analysts recently commented on the stock. Morgan Stanley reduced their price target on shares of JPMorgan Chase & Co. from $138.00 to $135.00 and set an “overweight” rating for the company in a research report on Monday, April 30th. Jefferies Group reiterated a “buy” rating and issued a $122.00 price target on shares of JPMorgan Chase & Co. in a research report on Monday, April 16th. BMO Capital Markets reiterated a “hold” rating and issued a $110.00 price target on shares of JPMorgan Chase & Co. in a research report on Friday, April 13th. HSBC assumed coverage on shares of JPMorgan Chase & Co. in a research report on Wednesday, April 11th. They issued a “hold” rating and a $111.00 price target for the company. Finally, Vining Sparks reiterated a “buy” rating and issued a $130.00 price target on shares of JPMorgan Chase & Co. in a research report on Friday, April 6th. Two investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and fourteen have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $112.75.

In related news, Director Mellody L. Hobson purchased 18,000 shares of the business’s stock in a transaction dated Monday, April 16th. The stock was acquired at an average price of $111.05 per share, for a total transaction of $1,998,900.00. Following the acquisition, the director now directly owns 864 shares of the company’s stock, valued at approximately $95,947.20. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Todd A. Combs purchased 13,000 shares of the business’s stock in a transaction dated Monday, May 14th. The stock was bought at an average price of $114.61 per share, with a total value of $1,489,930.00. Following the acquisition, the director now directly owns 18,277 shares in the company, valued at $2,094,726.97. The disclosure for this purchase can be found here. Company insiders own 0.73% of the company’s stock.

JPMorgan Chase & Co. Profile

JPMorgan Chase & Co operates as a financial services company worldwide. It operates through four segments: Consumer & Community Banking, Corporate & Investment Bank, Commercial Banking, and Asset & Wealth Management. The Consumer & Community Banking segment offers deposit and investment products and services to consumers; lending, deposit, and cash management and payment solutions to small businesses; residential mortgages and home equity loans; and credit cards, payment processing services, auto loans and leases.

Want to see what other hedge funds are holding JPM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for JPMorgan Chase & Co. (NYSE:JPM).

Institutional Ownership by Quarter for JPMorgan Chase & Co. (NYSE:JPM)